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Abstract: 
While radiation exposure related to natural sources plays a minor role, medicine-related exposure, 
represents, to date, a major exposure source. Within this exposure interventional electrophysiology 
is a relevant contributor. Unfortunately no safe dose in radioprotection exists, the negative acute and 
long term effects of radiological exposure may emerge at any radiation exposure dose. For this 
reason patients and physicians should be aware of the risk of radiation exposure and the benefits of 
the imaging/procedure balanced by the required radiation exposure. Given this, performing a near to 
zero x-rays transcatheter ablation procedure should therefore represent an aim for all 
electrophysiological lab. Fortunately, the introduction of electroanatomic mapping systems, have 
provided the possibility to perform simple and complex electrophysiological procedures avoiding, 
or at least, limiting the use of radiations. The present review summarizes state of the art of 
feasibility and safety of the near to zero approach for the main electrophysiological procedures, 
highlighting the potential health benefits.  
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Introduction 
Over the last two decades, the field of cardiac electrophysiology has undergone tremendous change 
and evolution.  The scope of available therapies has widened considerably, and hitherto 
“untreatable” arrhythmias have become commonplace in most laboratories. More complex 
arrhythmia substrates such as atrial fibrillation, atypical atrial flutter, and ventricular tachycardia are 
no longer relegated to medical therapy, however these more extensive ablative procedures result in 
longer procedural times, and consequently, longer fluoroscopy times. Given that considerable 
evidence exists as to hazards of this exposure to both the patient and the medical personnel, 
developing technologies and techniques to reduce fluoroscopy use in the electrophysiology 
environment is crucial1.   
The advent of three-dimensional mapping and cartographic systems originally introduced to allow 
electrophysiologists to target more challenging arrhythmias, have also helped to reduce fluoroscopy 
times during complex procedures. Beyond offering three-dimensional views of the cardiac 
chambers, these systems provide information about activation and voltage, integration of other non-
fluoroscopic imaging modalities, visualization of catheters within 3-D geometry, and lesion 
localization as well as catheter contact force sensing. These same technologies can be used to 
reduce radiation exposure in the more common “standard” electrophysiology procedures as well, 
thereby advancing our field towards the dream of near-zero radiation interventions. 
 
Biological effects of radiation and evidence of harm.  
Radiation exposure related to natural sources is relatively minimal, whereas nowadays, medicine-
related exposure is considered a major exposure source2. Biological effects of radiation are well 
known. Hydroxyl radicals created by X ray interaction with water molecules interact with the DNA 
causing strand breaks or base damage.  In addition X-rays also ionize DNA directly. Cellular 
clearance and repair mechanisms limit oxidative damages to the DNA.  However, when double 
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strand damages rather than point mutations occur, radiation related injury can be caused. In general, 
radiation injuries are induced by the stochastic mechanism or the deterministic effect. The 
stochastic mechanism represents an unpredictable, unrepaired radiation damage to the DNA of a 
limited, potentially single, number of viable cells. The deterministic effect, instead, occurs when a 
significant, predictable number of existing cells are sufficiently damaged to cause a directly 
observable injury. Radiological induced damage can be evident following both acute exposition (eg 
radiation induced skin injuries) or during long term follow up. In medicine, both radiological 
examinations (eg. computed tomography, and scintigraphy scans) and several interventional 
procedures (eg. percutaneous coronary intervention, arrhythmia ablation) can result in exposure to a 
significant amount of radiation. In fact, data from large sample size observational studies reported 
an increased malignancy rate, over a long term follow up, both for patients undergoing radiological 
examinations than electrophysiological procedures3.  An intervention such as atrial fibrillation 
ablation, for example, exposes patients to a dose of around 15 mSv (ranging from 1-60 mSv), 
increasing the absolute lifetime risk of a fatal cancer in an adult by about 0.08% (considered on a 
background fatal cancer risk of about 20%) 4,5 and this biological harm is obviously even higher 
within the paediatric population. 6,7. Additionally, one must consider this exposure risk not only for 
the patient but also for physicians and lab personnel dealing with radiation use in their routine 
clinical practice. Low dose exposures are also related to biological damage8. It has been estimated 
that an interventional cardiologists presents a median radiation exposure per year equivalent to 
approximately 250 chest X-rays (5mSv), a two to three times higher dose compared to a typical 
radiologists9 and this has, recently been related to an increased risk of cognitive impairment and 
brain malignancy (in particular on the left side) 10,11. For these reasons, in the attempt to avoid an 
uncontrolled increase in radiation exposure and consequent risks, the American College of 
Cardiology stated that the risk of radiation exposure always needs to be balanced by the benefits of 
the imaging/procedure itself. Based on the following three principles: justification, optimization, 
and responsibility for dose limitation, all interventional laboratories should therefore mandatory be 
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guided by the ‘ALARA’ (radiation doses ‘As Low As Reasonably Achievable’) principles12. In the 
following sections,  we will review systems and techniques that are already showing significant 
reductions in radiation exposure during interventional electrophysiology procedures. 
 
3D mapping systems in Electrophysiology 
Electrophysiological procedures were originally performed using fluoroscopic guidance  to 
introduce and position mapping and ablation catheters within the heart. Three-dimensional mapping 
systems have emerged as an alternative to fluoroscopy and have become the only viable method for 
limiting or avoiding radiation exposure.  To date, four 3-D mapping systems (Table 1) are widely 
used to visualize electrophysiology catheters without X-rays: EnSite NavX and Mediguide 
technologies (both by St. Jude Medical, St Paul, Minnesota, USA), Carto (Biosense Webster, 
Diamond Bar, California, USA), and Rhythmia (Boston Scientific San Jose, CA. 95134 USA).  
The EnSite NavX relies on three pairs of nominally orthogonal skin patches in x-y and z-axis 
positioned on the patient’s chest. An additional patch positioned on the abdomen serves as a 
reference during the initial phase of catheterization while advancing the catheters up the iliofemoral 
venous axis. Electrodes from standard electrophysiology catheters sense the electrical signals 
transmitted between the surface electrode patches. The system collects electrical data from the 
catheters and uses this information to track or navigate their movement, construct 3D models of the 
chamber and create activation and voltage maps 13. More recently the same company has improved 
the tools for a non fluoroscopic approach by introducing the Mediguide, technology. This system 
enables organ motion on established methods of 3D catheter localization (4-dimensional catheter 
tracking) 14 providing the possibility to move catheters into previously acquired fluoroscopic loops. 
Pre-acquired ecg and respiration triggered biplane short sequences of conventional fluoroscopic 
frames allow traditional catheter and structure visualisation tracking within dynamic, virtual cardiac 
chamber models (4D model). The system is based on a dynamic electromagnetic field integrated 
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with a miniaturized single coil sensor mounted on dedicated electrophysiology catheters and a 
reference sensor attached to the patient’s chest 15. In fact, given these features, Mediguide 
technology, is not only dedicated to arrhythmia ablation procedures but is also useful in other 
procedures requiring long fluoroscopy time exposure, as cardiac resynchronization implantation 16.   
The Carto system, in its present third generation (Carto 3), instead is based on six skin patches 
positioned on patient’s chest and back. These patches, together with a location pad technology (with 
9 coils), create a magnetic field in which catheter movements can be detected. As the catheter 
moves around the chamber, a multitude of such associated locations are created throughout the 
visited area, and stored by the system. The result is a calibrated current-based field. Advanced 
Catheter Location Technology combines the magnetic location technology with current based 
visualization data in a virtual chamber reference system built by catheter movements. As with most 
of the other systems, this technology offers the possibility of merging this virtual chamber with a 
preacquired anatomical image (e.g. magnetic resonance or computed tomography) allowing 
physicians to navigate catheters in an accurate representation of the patient’s anatomy. Also with 
this system, activation mapping information, during arrhythmias or sinus rhythm, may be projected 
to the map with a color coded mode, useful for guiding the ablation to the origin of the arryhthmia. 
A further refinement has come with the recent implementation of Carto-Univu, a module permitting 
real-time catheter tracking superimposed on pre-recorded cine loops.   
The most recently introduced mapping system, Rhythmia, is based on both magnetic and impedance 
localization, reaching a position accuracy of 1-2 mm. This system is based on an open architecture 
permitting the choice of  different diagnostic catheters.  However, activation and substrate mapping 
can be performed only with a dedicated catheter (IntellaMap Orion™) that has the peculiarity of 
being a basket, high resolution mapping catheter with 64 low-noise electrodes and 2.5 mm inter-
electrode spacing. Thanks to the latter and an advanced point acquisition software and process, this 
system is able to generate, by automated and continuous mapping, accurate, high-resolution 3D 
electroanatomical maps. 
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Near zero fluoroscopy approach.  
As discussed above, performing electrophysiological procedures with minimal radiological 
exposure is of paramount relevance, both for patients and physicians in order to avoid both acute 
and longer term radiation related injuries.  The use of the aforementioned technologies to reduce 
radiation exposure and the state of art of feasibility and safety for the most frequently encountered 
electrophysiological procedures are discussed below. 
Typical atrial flutter Typical atrial flutter is an atrial arrhythmia maintained by an anatomical re-
entry localized in the right atrium. In this arrhythmia, the portion between the inferior vena cava 
(IVC) and the annulus of the tricuspid valve is the critical isthmus and the target of the 
percutaneous ablation procedure 17. Due to the unsatisfactory success rates of antiarrhythmic drugs, 
to date, percutaneous ablation of typical atrial flutter represents the first line approach18. Given the 
relatively simple anatomic positioning of catheters to treat this arrhythmia, near zero fluoroscopy 
approaches for typical atrial flutter ablation have been reported for the last ten years19, 20, 21, 22, 23. The 
clear evidence emerging is that 3D real time electroanatomic mapping system broadly reduced 
fluoroscopy exposure without affecting procedure safety and outcome.  In a recent study by Macias 
et al 24, a zero fluoroscopy approach was attempted in all consecutive procedures of typical atrial 
flutter. In this series, a duo-decapolar catheter and an irrigated-tip ablation catheter were inserted 
via two punctures in the femoral vein and fluoroscopy was to be used only in case of challenging 
catheter positioning. In over 60 cases, no fluoroscopy was used for about 90% of the procedures. 
Even more recently Schoene et al 25 systematically applied Mediguide technology to 20 patients 
undergoing percutaneous ablation of cavo-tricuspid isthmus reporting no difference both in terms of 
freedom from recurrences, safety, and procedure duration while achieving a significant radiation 
exposure reduction.  
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Atrioventricular nodal re-entrant tachycardia. Atrioventricular nodal reentrant tachycardia is 
perhaps the most frequently encountered supraventricular tachycardia (SVT) in the 
electrophysiology lab. Patients afflicted by this condition are young, mostly female, and have little 
other cardiac conditions. Given the high success and low complication rates, transcatheter ablation 
is considered first line therapy in this population 26. Since it may be performed in centers with 
differing levels of experience, fluoroscopy times for this procedure are quite variable.  Further, in 
younger children or in women of child-bearing age, the potential for radiation exposure is non-
negligible. 
The previously described mapping systems have typically been utilized in more difficult arrhythmia 
substrates for which three-dimensional views of the heart were more useful than standard 
fluoroscopic views. However, Kopelman et al initially reported on the use of nonfluoroscopic 
mapping systems for a common AVNRT 27.  As would be intuitively expected, fluoroscopy times 
were significantly decreased when compared to conventional approach (4.2+/-1.4 vs 15.9+/-6.4 
min). Importantly, this did not impact negatively on success and complication rates and total 
intervention times. Evidently, interest for this in the pediatric population led to similar reports 
confirming diminished fluoroscopy times 28.  The feasibility of eliminating x-ray use altogether by 
using a 3D mapping system was demonstrated in a relatively small pediatric study showing a 95% 
reduction in fluoroscopy time with 24 of 30 patients requiring no fluoroscopy whatsoever 29. The 
“near-zero” radiation objective has been achieved in subsequent studies using the NavX system for 
all steps of the procedure instead of fluoroscopy, other than in a variety of arrhythmias, also for 
atrioventricular nodal reentry tachycardia 30,31.   
In fact, the most recent innovation of the systems permitting real-time catheter tracking 
superimposed on pre-recorded cine loops, as Mediguide (St Jude Medical) (Figure 1) and Carto-
Univu (Biosense Webster) have facilitated this approach also in physicians fond of traditional 
fluoroscopic views.  These systems are proving sufficiently versatile and are permitting to reduce 
radiation exposure even further than “conventional” 3D mapping32,33. 
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Atrioventricular re-entrant tachycardia. Reciprocating atrioventricular reentry tachycardia (AVRT) 
is a supraventricular arrhythmia maintained by the presence of an accessory pathway (Figure 2). 
Given the typical young age of patients involved and the high efficacy of the treatment, 
radiofrequency ablation is here again considered the first line option.  Conversely, for the same 
reason, radiation exposure due to an interventional approach in these patients has been of concern. 
Drago et al 34 reported their experience on 22 paediatric patients in whom a non-fluoroscopic 
approach was attempted using the Carto mapping system. In this series, ablation success rate was 
95% and no complications occurred. A more recent study reported on the systematic use of a a non-
fluoroscopic approach in a larger cohort of 328 patients35. This group consisted of 35 patients with 
AVRT whereas patients with left sided accessory pathway or those who needed a transeptal 
puncture were excluded from the study.  Procedural success was achieved in 99.1% of cases and in 
94.7% the procedure was completed without any fluoroscopy use at all. A wider experience has 
been recently reported by Scaglione et al 36. In this series a total no fluoroscopic approach was used 
in 44 consecutive paediatric patients with planned accessory pathway ablation. Right chambers 
were accessed through a venous transfemoral approach while a retrograde transaortic approach was 
used to access mitral annulus. Only three cases of  left sided accessory pathway were ablated 
through a patent foramen ovalis. In this experience a total of 47 accessory pathways (left sided 
45%) were ablated without the use of fluoroscopic guidance.  A multicentre, randomized, controlled 
experience has recently become available in this group of patients, dubbed the NO PARTY Trial 37.  
It is a prospective approach of no fluoroscopy use based on a 3D mapping system and was adopted 
in 262 patients undergoing electrophysiological study for supraventricular tachycardia (SVT). In 
this experience, 72% of procedures were performed without any use of fluoroscopy. Unfortunately, 
in this setting, left sided accessory pathways requiring transeptal puncture were not studied. As 
discussed subsequently in the section on, atrial fibrillation ablation, intracardiac echography (ICE) 
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may eventually play a role in reducing fluoroscopy exposure during transeptal puncture 38, but such 
an approach still needs to be standardized and validated.  
 
Ventricular tachycardia  Percutaneous ablation of ventricular tachycardia (VT) has been 
increasingly recommended (Figure 3) but is more frequently performed in higher volume, more 
experienced centers. Ventricular tachycardia may be triggered by an ectopic focus or, especially in 
case of an underlying cardiomyopathy, by an area of  slow conduction (eg. scar due to a previous 
myocardial ischemia) localized in the myocardial muscle mass, creating the ideal substrate for re-
entry triggered arrhythmias. In any case, the ablation procedure necessitates identification of  the 
ectopic spot and/or the critical isthmus of the arrhythmia. For both right and left sided ventricular 
tachycardias, 3D electroanatomic mapping systems have the potential to significantly reduce 
fluoroscopic exposure. In addition to this, the ability to perform substrate mapping (based on both 
voltage and activation maps) in sinus rhythm together with the detection of fractioned or late 
potentials (seen in the scar areas in underlying ischemic heart disease) holds the great advantage of 
identifying ablation targets without mandatory inducing and/or maintaining the clinical arrhythmia 
(commonly not well tolerated). 39. The first study looking at the feasibility of a near to zero 
approach was in the treatment of right ventricular outflow tract (RVOT) premature ventricular 
contractions (PVCs) 40 both in adults and in the pediatric population41. More recently 3D 
electroanatomic mapping proved feasible for treating PVCs in adult patients with complex 
congenital heart disease 42. Overall it is becoming clear that, in this setting, activation mapping 
during ventricular arrhythmia together with substrate mapping enhance the clinical utility of 3D 
mapping systems beyond radiation exposure reduction.  Further, left-sided ventricular tachycardias 
not amenable to a retrograde approach and requiring transeptal acces remain, for the moment, best 
suited to fluoroscopic guidance. 
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Atrial fibrillation Atrial fibrillation (AF) is the most common arrhythmia in the adult population 
(particularly in older patients),  and it represents the widest indication for transcatheter ablation. In 
fact, considering the limited efficacy of antiarrhythmic therapy, often associated with relevant side 
effects, percutaneous ablation has emerged in recent years as the perhaps the most promising 
therapeutic strategy. Two main mechanisms are involved in AF onset: triggers and perpetuation. 
Arrhythmia triggers are commonly localized in the pulmonary veins and this mechanism of 
arrhythmia is particularly relevant in young patients without underlying cardiomyopathy (and atrial 
remodelling) suffering paroxysmal AF. Perpetuating factors, instead, are related to atrial 
enlargement, tissue fibrosis and consequent shortening of atrial refractory period. This mechanism 
is particularly observable within patients with underlying cardiomyopathy suffering persistent or 
long-standing AF.  
Three-dimensional real-time reconstruction systems able to evaluate instantaneous catheter 
positioning, respiration triggered movement and the offering the possibility of integrating 
radiological images are allowing users to perform pulmonary vein isolation (Figure 3) and left atrial 
substrate modification with minimal use of fluoroscopy 43, Errore. Il segnalibro non è definito.,Errore. Il segnalibro 
non è definito.. In addition to non fluoroscopic mapping systems, other technologies have emerged to 
facilitate AF ablation: contact force technology, for example, is able to monitor and measure the 
tissue/catheter contact in order to avoid excessive or insufficient forces on the tip of the catheter.   
After a brief learning curve44, this technology further supports manoeuvring in a zero fluoroscopy 
setting45. In a multicentre study on 240 consecutive patients undergoing catheter ablation of AF, 
adoption of a 3D mapping system proved to significantly impact routine activity in all centres 
involved, achieving an average fluoroscopy time decrease from 26 ± 15 min to 16 ± 12 min (P < 
0.001) Errore. Il segnalibro non è definito.. More recently a prospective, randomized, blinded trial, clearly 
showed that the systematic use of third generation mapping systems reduced fluoroscopy exposure 
in patients undergoing AF ablation, without increasing procedure duration or affecting safety and 
short-term efficacy 46. Eventually the systematic use of electroanatomic mapping systems integrated 
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with preacquired imaging, in this case cardiac magnetic resonance with use of oral gadobenate 
dimeglumine, 47 also presents the advantage of visualizing the esophagus in relation to points of 
radiofrequency delivery. This anatomical correlation indeed holds the potential to limit atrio-
esophageal fistulas, a rare but potentially fatal periprocedural complication of percutaneous AF 
ablation. As previously stated, to date, the only remaining issue that limits a complete zero 
fluoroscopy approach for AF ablation and other left sided arrhythmias not approachable by 
retrograde aortic access is the transeptal puncture. In this respect, preliminary data suggest that 
intracardiac ultrasound echography (ICE) may become a routine strategy to guide transeptal 
puncture without fluoroscopy use Errore. Il segnalibro non è definito., Errore. Il segnalibro non è definito. . A recent 
experience in 80 patients showed that by using a third generation mapping system, contact force 
technology and ICE guiding transeptal puncture, RF ablation of AF was not only feasible without 
fluoroscopy but also safe, without affecting procedure duration, RF application time and mid-term 
efficacy 48. Mansour et al 49 recently reported on the use of the equipment compatible with the 
Mediguide Technology in order to perform a transeptal puncture without fluoroscopy in a small 
population of consecutive patients.  In fact, by the use of a guidewire with a magnetic sensor on the 
tip, the authors managed to perform the transeptal puncture with a very low fluoroscopy exposure.  
 
Reasons for performing a fluoroscopy-free procedure  
How is radiation exposure risk perceived by the patient? How many patients would decline 
undergoing a diagnostic imaging scan or an interventional procedure to avoid increasing their 
lifetime cancer risk? To date, awareness on the topic is poor. In our opinion patients need to be 
sensitized to radiation exposure risks. How is radiation exposure risk perceived by physicians? 
Unfortunately, although negative long-term effects of radiation exposure are relevant, awareness is 
suboptimal in physicians as well. 
Though extremely simplified, to provide a significant highlight on the expected results of an 
increased awareness on the topic, we suggest circulating the findings of the recent NO-PARTY 
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Trial 37 described above. This study, has reported a potential 96% reduction in the estimated risks of 
cancer incidence and mortality and  a significant reduction in estimated years of life lost and of life 
affected by a zero fluoroscopy approach compared to the conventional approach. Performing a 
conventional ablation procedure in patients with 35 years of age will result in 1 week of “life lost” 
and 2 weeks of “life affected” in contrast with 5 and 12 hours, respectively by adapting a fluoroless 
procedure  Other compelling risk reductions are reported in Table 2. 
 
 
Future perspective. Biological effects of radiation are known and in our opinion, respecting the 
ALARA principles should mandatory both for health of the operators and the patients. In the last 
two decades, technology has significantly improved, we can currently use the systems and 
techniques described previously to achieve relevant radiation exposure reductions. The reviewed 
experiences have demonstrated that a “near to zero approach” is indeed feasible, without affecting 
safety, efficacy, and procedure duration. The medical community and patients need to become 
aware  of this possibility to permit and support the evolution from traditional electrophysiology 
practices towards approaches that significantly limit the use of fluoroscopy. The only significant 
issue that remains is how to minimize fluoroscopy during the transeptal puncture for left-sided 
procedures, and achieving this could potentially nearly eliminate radiation use.  Presently, the usual 
anatomic landmarks used to guide transeptal punctures can be identified on fluoroscopy but not by 
electroanatomic mapping systems.  The use of other technologies such as ICE, transoesophageal 
echocardiography or sensor enabled guidewires are still relatively cumbersome, requiring 
adjunctive vascular access, deep sedation, and/or extra intravascular material.  Once the transeptal 
needle becomes  traceable in any of the available non-fluoroscopic mapping systems, a total non-
fluoroscopic approach will be possible for the vast majorities of electrophysiological procedures.  
In conclusion, strongly motivated by evidence of feasibility and of a clear measurable cancer risk 
reduction, all electrophysiology laboratories should aim to significantly reduce X-ray exposure by 
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the judicious of available systems and technology. Meanwhile, continued technological progress is 
clearly showing that the dream of a complete zero fluoroscopy approach for all arrhythmias 
management is close at hand. 
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Table 1. Lifetime Attributable Risks of Cancer Mortality 
Lifetime Attributable Risks of cancer mortality with 95% confidence intervals from minimal fluoroscopic 
approach (N=118) and conventional approach (N=113) ablations in function of age at exposure and sex 
(number of cases in 100.000). Data From Casella M et al Europace 2015. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cancer Age 
Minimal Fluoroscopic Approach  Conventional approach 
Men Women  Men Women 
All Cancers 15 4.1 (2.1, 7.0) 5.1 (3.3, 7.8)  150 (90, 237) 204 (144, 291) 
 25 3.3 (1.5, 6.0) 4.0 (2.4, 6.2)  116 (65, 189) 151 (103, 220) 
 35 3.1 (1.3, 5.7) 3.5 (2.0, 5.7)  103 (55, 172) 130 (86, 192) 
 45 3.2 (1.3, 5.8) 3.5 (1.9, 5.7)  104 (54, 174) 127 (83, 188) 
Breast 15  0.46 (0.33, 0.66)   20.4 (14.6, 28.9) 
 25  0.28 (0.20, 0.39)   12.3 (8.7, 17.3) 
 35  0.16 (0.12, 0.23)   7.3 (5.2, 10.3) 
 45  0.10 (0.07, 0.14)   4.2 (3.0, 5.9) 
Lungs 15 0.81 (0.38, 1.76) 1.61 (1.09, 2.35)  35 (17, 77) 71 (48, 103) 
 25 0.56 (0.27, 1.22) 1.11 (0.75, 1.62)  25 (12, 54) 49 (33, 71) 
 35 0.47 (0.22, 1.02) 0.92 (0.62, 1.34)  21 (10, 45) 40 (27, 59) 
 45 0.46 (0.22, 1.01) 0.91 (0.61, 1.32)  20 (10, 44) 40 (27, 58) 
Thyroid 15 0.0259 (0.0068, 0.0977) 0.0687 (0.0183, 0.2552)  1.14 (0.30, 4.30) 3.02 (0.81, 11.23) 
 25 0.0114 (0.0030, 0.0431) 0.0301 (0.0080, 0.1117)  0.50 (0.13, 1.89) 1.32 (0.35, 4.92) 
 35 0.0050 (0.0013, 0.0189) 0.0131 (0.0035, 0.0487)  0.22 (0.06, 0.83) 0.58 (0.15, 2.14) 
 45 0.0022 (0.0006, 0.0082) 0.0057 (0.0015, 0.0210)  0.10 (0.03, 0.36) 0.25 (0.07, 0.93) 
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Table 2. Available electroanatomic mapping software 
Different electroanatomic mapping software to date available to perform minimally fluoroscopic exposure 
procedures. 
 
Commercial 
name Ensite NavX 
Mediguide 
Technology  Carto 3 system Localisa Rhythmia 
Localization 
based system 
Voltage guided 
field 
Low powered 
electromagnetic 
field 
Magnetic field Electrical field Magnetic and impedence field 
Movement 
sensibility 
(mm) 
1.4 0.5 1.0 1.4 1-2  
Multipoint 
mapping 
catheter 
available 
Yes (max 128 
point) 
Yes (max 10 
point) 
Yes (max 20 
point) No 
Yes (max 64 
point) 
Open 
architecture 
system 
Yes No Yes Yes Yes 
Possibility to 
merge with 
preacquired 
images 
Yes No Yes No No 
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Figure 1. Example of crioablation of a slow pathway by the use of the Navex System (St. Jude 
Medical). In white hissian catheter (Supreme electrophysiology catheter CRD2 5F quadripolar St 
Jude Medical). In green decapolar diagnostic catheter in the coronary sinus (Inquiry steerable 
diagnostic catheter, 6F decapolar St Jude Medical). In blue diagnostic catheter for the right ventricle 
(Spike Ultra LC R Josephson curve, 6 F quadripolar, FIAB). In Yellow the ablator catheter 
(CrioCath Freezor Xtra 5, 8F quadripolar, Medtronic). Panel A. Right anterior oblique view (left 
panel) and right anterior oblique view (right panel) showing fast anatomical reconstruction of the 
right chambers to guide catheter positioning. Panel B. Left anterior oblique view (left panel) and 
left lateral view (right panel) showing crioenergy deliveriy at slow pathway potential site (yellow 
traces). 
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Figure 2. Example of ablation of a left sided accessory pathway using a minimal fluoroscopy 
approach by EnSite NavX and Mediguide systems. In white hissian catheter (Supreme 
electrophysiology catheter CRD2 5F quadripolar St Jude Medical). In green decapolar diagnostic 
catheter for coronary sinus (Inquiry steerable diagnostic catheter, 6F decapolar St Jude Medical). In 
blue diagnostic catheter for right ventricle (Spike Ultra LC R Josephson curve, 6 F quadripolar, 
FIAB). In Yellow ablator catheter (Therapy Cool Path Duo, 8F quadripolar, St Jude Medical) 
Panel A.  Endocavitary electrograms during ventricular stimulation showing, during the first beats, 
eccentric retrograde conduction with first atriogram on the distal coronary sinus (CS 1,2). During 
Radiofrequency ablation retrograde of the accessory pathway retrogade conduction is modified and, 
in the last beat, eliminated. Panel B: EnSite NavX system views of the left atrium (right panel 
postero-anterior view, left panel left anterior oblique view) electroanatomic 3D reconstruction 
showing the position of the ablation catheter, the decapolar catheter in the coronary sinus and the 
catheter for the right ventricle. Panel C: Mediguide left anterior oblique view showing ablation 
catheter position (yellow) in the previously acquired fluoroscopic loop.  
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Figure 3. Example of ventricular tachycardia ablation in different clinical context. Note ablator 
cathether (Navistar Smart Touch curve FJ, 8 F quadripolar, Biosense Webster) Example of right 
ventricle outflow tract tachycardia managment with a zero fluoroscopy approach (Carto 3). Panel A 
shows unipolar (left panel, antero-posterior view) and bipolar (right panel, posterior tricuspid anulus 
centred view) voltage maps simultaneously during chamber navigation. Panel B show activation 
mapping during tahycardia (centre panel left lateral view, right panel more posterior view), note 
earliest site of activation in the posterior  portion of the right ventricle outflow tract with a complete 
negative unipolar signal on ablator traces (right panel, yellow trace on top) and sharp bipolar signal 
(right panel blue trace on top) preceding QRS onset on superficial ecg. Note contact force 
technology advising the physician of 3 gr pressure on the ventricular wall. Radiofrequency 
delivering on this site (red dots on centre panel) resulted in arrhythmia interruption and sinus 
rhythm restoration. In the lower section an example of left ventricle ventricular tachycardia in a 
patient with coronary artery disease managed by Carto 3 mapping system. Voltage map documented 
a wide scar area involving the entire apex of the left ventricle (panel C). The activation mapping 
during ventricular tachycardia showed earliest activation in the anterior portion of the periscar area 
(panel D), site of a mid-diastolic fragmented potential of 150 msecs preceding QRS onset. 
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Figure 4. An Atrial Fibrillation ablation case performed by Carto 3 system. Panel A. Fluoroscopic 
left anterior oblique projection showing a decapolar catheter in the coronary sinus (Webster CS 
catheter Ez steer, 7F decapolar, Biosense Webster) and the device useful to perform transseptal 
access (BRK™ Transseptal Needles and Swartz Braided Transseptal guiding introducer St Jude 
Medical). To date to perform transseptal access fluoroscopy is still necessary. Panel B: fast 
anatomic mapping (FAM, performed with Lasso Catheter, circular decapolar 7F catheter, Biosense 
Webster) permits to obtain, by catheter movement, a virtual electro-anatomic 3D left atrium image 
that is then merged to the preintervention imaging scan (in this case cardiac RMI) Panel c: postero-
anterior and left lateral Carto views showing ablation points obtaining pulmonary vein isolation 
(ablator catheter Navistar Smart Touch FJ, 8F quadripolar, Biosense Webster), please note 
proximity of the posterior wall of the left atrium to the oesophagus (visualized at preintervention 
MR scan). 
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